ANHYDROL FORTE

국가: 이스라엘

언어: 영어

출처: Ministry of Health

유효 성분:

ALUMINIUM CHLORIDE HEXAHYDRATE

제공처:

TRUPHARM MARKETING 1985 LTD.

ATC 코드:

D09AA08

약제 형태:

SOLUTION

구성:

ALUMINIUM CHLORIDE HEXAHYDRATE 20 %W/V

관리 경로:

TOPICAL

처방전 유형:

Not required

Manufactured by:

DERMAL LABORATORIES LTD., UK

치료 그룹:

ALUMINIUM CHLOROHYDRATE

치료 영역:

ALUMINIUM CHLOROHYDRATE

치료 징후:

For the topical treatment of hyperhydrosis specifically involving axillae, hands or feet.

승인 날짜:

2023-05-31

환자 정보 전단

PATIENT PACKAGE INSERT IN ACCORDANCE WITH
THE PHARMACISTS’ REGULATIONS (PREPARATIONS) - 1986
This medicine is dispensed without a doctor’s prescription
ANHYDROL FORTE
SOLUTION IN A ROLL-ON BOTTLE
THE ACTIVE INGREDIENT AND ITS CONCENTRATION:
20% Aluminum Chloride Hexahydrate
Inactive and allergenic ingredients: see section 6 “Further
Information”.
READ THIS LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE USING THE MEDICINE.
This
leaflet contains concise information about the medicine. If you have
further
questions, refer to the doctor or the pharmacist.
This medicine is intended for children, adults and elderly. You must
use the
medicine in the proper manner. Consult the pharmacist if you need
further
information. Refer to the doctor if the symptoms worsen.
1. WHAT IS THE MEDICATION INTENDED FOR?
The medication Anhydrol Forte is a treatment for excessive sweating of
the
armpits, hands or feet.
The active ingredient, aluminum chloride hexahydrate reduces sweating
by
blocking sweat ducts in the skin, and provides a deodorant action by
killing
the bacteria that cause body odour.
THERAPEUTIC GROUP: Aluminum and chlor compounds.
2. BEFORE YOU USE ANHYDROL FORTE
DO NOT USE ANHYDROL FORTE
• If you are sensitive )allergic( to the active ingredient or to the
other
ingredients that the medication contains, see section 6 for inactive
ingredients in this medication.
SPECIAL WARNINGS REGARDING USE OF THIS MEDICINE
• Limit application to sweating areas only, on the armpits, hands or
feet.
• Make sure that the treated areas are COMPLETELY DRY before
applying the
medication )see section 3(.
• Do not use on broken or irritated skin.
• When treating the armpits, do not shave or use hair-removal
products within
12 hours before or after applying Anhydrol Forte.
• Keep it away from the eyes, nose and mouth.
• AVOID SPILLING CONTENTS OF THE BOTTLE as this may cause damage to
you,
your clothing and possessions )see section 4(.
• Do not shake the bottle.
• Do not attempt to remove the roller ball head.
• Keep the cap

제품 특성 요약

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Anhydrol Forte
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Aluminium chloride hexahydrate 20.0% w/v.
3
PHARMACEUTICAL FORM
Cutaneous Solution,
Clear, colourless, evaporative cutaneous solution.
4.
CLINICAL PARTICULARS
4.1.
THERAPEUTIC INDICATIONS
For the topical treatment of hyperhidrosis specifically involving
axillae, hands
or feet.
4.2.
POSOLOGY AND METHOD OF ADMINISTRATION
_For adults, children and the elderly. _
_ _
Apply to the affected sites at night; as required, and allow to dry.
Wash off in
the morning.
4.3.
CONTRA-INDICATIONS
Not to be used in cases of sensitivity to any of the ingredients.
4.4.
SPECIAL WARNINGS AND SPECIAL PRECAUTIONS FOR USE
Care should be taken to restrict the application to the affected sites
only.
Keep away from the eyes.
Care should be taken to avoid Anhydrol Forte coming into direct
contact with
clothing, polished surfaces, jewellery or metal.
Replace cap tightly after use.
4.5.
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTIONS
Do not bathe immediately before use and, if the axillae are treated,
do not
shave or use depilatories on this area within 12 hours before or after
use.
4.6
PREGNANCY AND LACTATION
No special precautions.
4.7.
EFFECTS ON ABILITY TO DRIVE AND USE MACHINES
None known.
4.8
UNDESIRABLE EFFECTS
If applied too frequently, Anhydrol Forte may cause irritation which
should be
treated with a mild topical hydrocortisone cream.
REPORTING OF SUSPECTED ADVERSE REACTIONS
Reporting suspected adverse reactions after authorisation of the
medicinal
product is important. It allows continued monitoring of the
benefit/risk balance
of the medicinal product. Any suspected adverse events should be
reported to
the Ministry of Health according to the National Regulation by using
an online
form: https://sideeffects.health.gov.il
4.9.
OVERDOSE
See section 4.8 above (undesirable effects).
5.
PHARMACOLOGICAL PROPERTIES
5.1.
PHARMACODYNAMIC PROPERTIES
Aluminium chloride is believed to denature the